低剂量大麻二醇增加了阿米特利普提林的血度:一项临床药物相互作用研究
Andriy A Gorbenko1,2, Titiaan E Post1, Pamela K Strugala1
1Centre for Human Drug Research, Leiden, The Netherlands.
British journal of clinical pharmacology
|December 16, 2025
概括
Cannabidiol (CBD) 的使用在健康志愿者中增加了阿米特林水平,表明了潜在的药物相互作用. 这一发现表明,在将CBD与阿米林结合使用时,特别是在慢性疼痛患者中,应谨慎使用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物新陈代谢 药物新陈代谢
- 大麻素研究 研究 大麻素研究
背景情况:
- 堪纳比迪 (CBD) 是一种非中毒的大麻化合物,经常被慢性疼痛患者服用止痛药使用.
- 以前的研究表明,CBD可以抑制细胞染色体P450 (CYP) 介导的药物代谢.
- 阿米特利普提林和特拉马多尔是常见的止痛药,通常与其他药物联合处方.
研究的目的:
- 为了研究CBD与止痛药阿米特利普提林和特拉马多尔之间的药理动力学相互作用.
- 描述CBD如何影响阿米和特拉马多的新陈代谢和血度.
主要方法:
- 这是一项开放的双向交叉研究,涉及13名健康参与者.
- 参与者接受了单独的阿米丁和特拉马多尔,随后与CBD联合使用.
- 药物动力学采样测量了药物和代谢物水平,直到剂量后24小时.
主要成果:
- CBD显著增加了阿米烯曲线下的面积 (AUC) 和最大度 (Cmax).
- 没有观察到特拉马多尔或其活性代谢物O-desmethyltramadol的AUC或Cmax的显著变化.
- CBD并没有显著改变阿米特利普提林活性代谢物诺特利普提林的药理动力学.
结论:
- 一次30毫克的CBD剂量在健康个体中显著影响阿米西林代谢.
- 在慢性疼痛患者中,更明显的CBD药物相互作用的可能性,特别是在长期服用和不同的饮食条件下.
相关概念视频
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
236
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
236
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
651
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
651
01:25Pharmacokinetics: Drug–Drug Interactions
319
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
319
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
602
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
602
01:29Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
331
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
331